High prevalence of ESBL-producing Escherichia coli isolates among hemodialysis patients in Portugal: Appearance of ST410 with the blaCTX-M-14 gene

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 4, 2012, Pages 423-425

  Correia, Susana ^a,b   Pacheco, Rui ^a,b   Radhouani, Hajer ^a,b   Diniz, João Carlos ^c   Ponce, Pedro ^c   Jones Dias, Daniela ^d   Caniça, Manuela ^d   Igrejas, Gilberto ^a   Poeta, Patrícia ^a,b  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^c NephroCare   (Portugal)

^d NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

Escherichia coli; Extended spectrum lactamase; Hemodialysis; Portugal

Indexed keywords

BETA LACTAMASE CTX M;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLA CTX M 1 GENE; BLA CTX M 14A GENE; BLA CTX M 15 GENE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FECES ANALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PORTUGAL; PRIORITY JOURNAL; REPLICON; SEQUENCE ANALYSIS;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; HUMANS; MICROBIAL SENSITIVITY TESTS; PORTUGAL; PREVALENCE; RENAL DIALYSIS; VIRULENCE FACTORS;

EID: 84869089503     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.08.017     Document Type: Article

References (11)

1. Canton R., Coque T.M. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006, 9:466-475.
2. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K.L., Threlfall E.J. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005, 63:219-228.
3. Clermont O., Bonacorsi S., Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000, 66:4555-4558.
4. Clermont O., Johnson J.R., Menard M., Denamur E. Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis 2007, 57:129-136.
5. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing - Seventeenth edition: informational supplement (M100-S17) 2010, CLSI, Wayne, PA.
6. Gonçalves A., Igrejas G., Radhouani H., Estepa V., Alcaide E., Zorrilla I., et al. Detection of extended-spectrum beta-lactamase-producing Escherichia coli isolates in faecal samples of Iberian lynx. Lett Appl Microbiol 2012, 54:73-77.
7. Johnson J.R., Johnston B., Clabots C., Kuskowski M.A., Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010, 51:286-294.
8. Marchaim D., Lazarovitch Z., Efrati S., Dishy V., Weissgarten J., Boldur I., et al. Serious consequences to the use of cephalosporins as the first line of antimicrobial therapy administered in hemodialysis units. Nephron Clin Pract 2005, 101:c58-c64.
9. Poeta P., Radhouani H., Igrejas G., Goncalves A., Carvalho C., Rodrigues J., et al. Seagulls of the Berlengas natural reserve of Portugal as carriers of fecal Escherichia coli harboring CTX-M and TEM extended-spectrum beta-lactamases. Appl Environ Microbiol 2008, 74:7439-7441.
10. Poirel L., Cattoir V., Nordmann P. Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front Microbiol 2012, 3:24.
11. Wirth T., Falush D., Lan R., Colles F., Mensa P., Wieler L.H., et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006, 60:1136-1151.